![Michael Davidson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Davidson
Directeur Général chez
FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Fortune : 31 M $ au 31/05/2026
Profil
Dr. Michael H.
Davidson, MD, is an Independent Director at BioAge Labs, Inc., a Chief Executive Officer & Director at NewAmsterdam Pharma Co. NV, an Independent Director at Tenax Therapeutics, Inc., a Chief Executive Officer & Executive Director at NewAmsterdam Pharma BV, a Chief Executive Officer & Executive Director at NewAmsterdam Pharma Corp., a Chief Executive Officer & Executive Director at NewAmsterdam Pharma Holding BV, a Professor at The University of Chicago Department of Medicine, a Chairman at SonoThera, Inc., a Director-Lipid Clinic & Professor at The University of Chicago, a Member at American College of Cardiology Foundation and a Member at American College of Chest Physicians.
He is on the Board of Directors at BioAge Labs, Inc., NewAmsterdam Pharma Co. NV, Abcentra, Inc., Tenax Therapeutics, Inc., Jocasta Neuroscience, Inc., Inositec AG, NewAmsterdam Pharma BV, NewAmsterdam Pharma Corp., NewAmsterdam Pharma Holding BV, Midwest Lipid Association, NanoPhoria Srl, Preventive Cardiology Institute, Inc. and Sonogene LLC.
Dr. Davidson was previously employed as an Independent Non-Executive Director by Silence Therapeutics Plc, a Director & Chief Scientific Officer by Trofi Nutritionals, Inc., an Independent Director by Caladrius Biosciences, Inc., a Chief Scientific & Medical Officer by Corvidia Therapeutics, Inc., an Independent Director by ABIONYX Pharma SA, a President by National Lipid Association, a Chief Medical Officer & Executive Vice President by Omthera Pharmaceuticals, Inc., and a President & Chief Executive Officer by Chicago Center for Clinical Research.
He also served on the board at Cerenis Therapeutics, Inc. He received his undergraduate degree from Northwestern University and a doctorate degree from The Ohio State University College of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2026 | 905 286 ( 0,77 % ) | 30 M $ | 31/05/2026 | |
TENAX THERAPEUTICS, INC. 0,01 % | 08/04/2026 | 2 881 ( 0,01 % ) | 34 197 $ | 31/05/2026 |
SILENCE THERAPEUTICS PLC 0,01 % | 31/12/2025 | 12 993 ( 0,01 % ) | 23 387 $ | 30/11/2025 |
BIOAGE LABS, INC. -.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Michael Davidson
| Sociétés | Poste | Début |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/04/2021 |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Directeur Général | 01/11/2022 |
| BIOAGE LABS, INC. | Directeur/Membre du Conseil | 01/03/2024 |
NewAmsterdam Pharma Corp.
 NewAmsterdam Pharma Corp. BiotechnologyHealth Technology Develops therapies in the fields of metabolic diseases, cardiovascular diseases, and liver diseases | Directeur Général | 01/08/2020 |
NanoPhoria Srl
 NanoPhoria Srl BiotechnologyHealth Technology Operates as a preclinical stage biotech company that develops non-viral drug delivery platform | Directeur/Membre du Conseil | - |
SonoThera, Inc.
 SonoThera, Inc. BiotechnologyHealth Technology Develops genetic medicines to treat the root cause of human diseases | Fondateur | - |
NewAmsterdam Pharma BV
 NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat dyslipidemia | Directeur Général | 01/08/2020 |
Jocasta Neuroscience, Inc.
 Jocasta Neuroscience, Inc. BiotechnologyHealth Technology Provides biological products development services to treat cognitive decline | Fondateur | 01/01/2021 |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Michael Davidson
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Michael Davidson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
29
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 29 |
|---|---|
Tenax Therapeutics, Inc.
 Tenax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes pharmaceutical therapeutic products | Health Technology |
Sonogene LLC | |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
Chicago Center for Clinical Research
 Chicago Center for Clinical Research Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABIONYX Pharma SA
 ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases | Health Technology |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Health Technology |
American College of Chest Physicians
 American College of Chest Physicians Miscellaneous Commercial ServicesCommercial Services Operates as chest medical associations | Commercial Services |
American College of Cardiology Foundation
 American College of Cardiology Foundation Medical/Nursing ServicesHealth Services Provides cardiovascular education services | Health Services |
Preventive Cardiology Institute, Inc.
 Preventive Cardiology Institute, Inc. The Preventive Cardiology Institute, Inc. is a company based in Napa, CA. | |
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs | Health Technology |
Abcentra, Inc.
 Abcentra, Inc. Miscellaneous Commercial ServicesCommercial Services Develops oxidized LDL blocking therapeutics for cardiovascular inflammation treatment | Commercial Services |
National Lipid Association
 National Lipid Association Miscellaneous Commercial ServicesCommercial Services Operates medical society focused on enhancing the practice of lipid management in clinical medicine | Commercial Services |
Midwest Lipid Association | |
NewAmsterdam Pharma BV
NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat dyslipidemia | Health Technology |
The Ohio State University College of Medicine
 The Ohio State University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Develops precision cardiovascular therapies | Health Technology |
Inositec AG
 Inositec AG Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops treatments for progressive vascular calcification and soft tissue disorders | Health Technology |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology Develops therapies obesity for metabolic diseases | Health Technology |
The University of Chicago Department of Medicine
 The University of Chicago Department of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Engages in research and development of transformative therapies for cardio metabolic diseases | Health Technology |
Jocasta Neuroscience, Inc.
Jocasta Neuroscience, Inc. BiotechnologyHealth Technology Provides biological products development services to treat cognitive decline | Health Technology |
NanoPhoria Srl
NanoPhoria Srl BiotechnologyHealth Technology Operates as a preclinical stage biotech company that develops non-viral drug delivery platform | Health Technology |
Trofi Nutritionals, Inc.
 Trofi Nutritionals, Inc. Specialty StoresRetail Trade Provides personal health services | Retail Trade |
NewAmsterdam Pharma Co. NV
 NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
SonoThera, Inc.
SonoThera, Inc. BiotechnologyHealth Technology Develops genetic medicines to treat the root cause of human diseases | Health Technology |
NewAmsterdam Pharma Corp.
NewAmsterdam Pharma Corp. BiotechnologyHealth Technology Develops therapies in the fields of metabolic diseases, cardiovascular diseases, and liver diseases | Health Technology |
